Search

everythinglearnresearchcommunity

for

Search:↓

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

New genes and pathways are important for testosterone production and male sexual development.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Reduced AR gene methylation may cause early pubic hair growth in girls.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Hair regrowth slows with age and can be affected by treatments that change enzyme activity in the skin.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Eating healthy, exercising, and changing behaviors are the best first steps to treat Polycystic Ovary Syndrome (PCOS).

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.